VERTEX PHARMACEUTICALS INC / MA Restructuring Reserve, Noncurrent
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Restructuring Reserve, Noncurrent of $0 as of 2017-12-31, per its 10-K filed 2018-02-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:RestructuringReserveNoncurrent · last filed 2018-02-15
- 2017-12-31: Restructuring Reserve, Noncurrent $0.00.
- 2017-09-30: Restructuring Reserve, Noncurrent $146.00K.
- 2017-06-30: Restructuring Reserve, Noncurrent $527.00K.
- 2017-03-31: Restructuring Reserve, Noncurrent $613.00K.
| Period end | Restructuring Reserve, Noncurrent |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-15 |
| 2017-09-30 | $146.00K 10-Q · filed 2017-10-30 |
| 2017-06-30 | $527.00K 10-Q · filed 2017-07-28 |
| 2017-03-31 | $613.00K 10-Q · filed 2017-04-28 |
| 2016-12-31 | $1.91M 10-K · filed 2018-02-15 |
| 2016-09-30 | $3.31M 10-Q · filed 2016-10-31 |
| 2016-06-30 | $4.80M 10-Q · filed 2016-08-01 |
| 2016-03-31 | $6.14M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $7.46M 10-K · filed 2017-02-23 |
| 2015-09-30 | $9.12M 10-Q · filed 2015-10-30 |
| 2015-06-30 | $9.68M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $8.36M 10-Q · filed 2015-05-04 |
| 2014-12-31 | $12.75M 10-K · filed 2016-02-16 |
| 2014-09-30 | $17.22M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $10.49M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $13.96M 10-Q · filed 2014-05-05 |
| 2013-12-31 | $14.07M 10-K · filed 2015-02-13 |
| 2013-09-30 | $16.28M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $17.00M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $17.55M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $18.57M 10-K · filed 2014-02-11 |
| 2012-09-30 | $19.56M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $20.15M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $20.77M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $21.38M 10-K · filed 2013-03-01 |
| 2011-09-30 | $21.48M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $23.05M 10-Q · filed 2011-08-09 |
| 2011-03-31 | $23.59M 10-Q · filed 2011-05-06 |
| 2010-12-31 | $24.10M 10-K · filed 2012-02-22 |
| 2010-09-30 | $27.34M 10-Q · filed 2010-10-28 |
| 2010-06-30 | $27.76M 10-Q · filed 2010-08-03 |
| 2010-03-31 | $27.00M 10-Q · filed 2010-05-03 |
| 2009-12-31 | $27.70M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |